JP Patent

JP7144935B2 — 癌のための治療方法及び診断方法

Assigned to Genentech Inc · Expires 2022-09-30 · 4y expired

What this patent protects

Patent listed against Balversa.

Drugs covered by this patent

Patent Metadata

Patent number
JP7144935B2
Jurisdiction
JP
Classification
—
Expires
2022-09-30
Drug substance claim
No
Drug product claim
No
Assignee
Genentech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.